SRx Health Solutions Reports 24.8% EMJX Returns; $55M Cash, No Debt

SRx Health Solutions announced strong paper-traded returns for its EMJX strategy, achieving +24.8% from February 11 to July 10, 2026, significantly outperforming Bitcoin's -4.2% decline during the same period. The company reported a robust financial position with $55 million in cash and short-term investments, no debt, and a net asset value of $3.07 per share as of June 30, 2026. Additionally, SRx Health Solutions declared a million-dollar aggregate cash dividend and authorized a share buyback program for up to 10 million shares, demonstrating confidence in its strategy and financial health.